Najat Khan

CIK 2020969 · CEO and President · last filed 2026-08-18

Najat Khan is a CEO and President who has filed 17 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing shows the insider had shares withheld for taxes covering $254.4K of RXRX on Aug 18, 2026. Across all open-market trades the lifetime net is −$929.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.46M

Companies

1

Total Filings

17

Lifetime Open-Market Net

-$929.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RXRX CEO and President 2,095,298 $3.56 $7.46M -$929.9K 13 2026-08-18

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-18 RXRX Tax (F) −80,498 -$254.4K EDGAR
2026-06-05 RXRX Sell (S) −23,588 -$84.5K EDGAR
2026-06-05 RXRX Notice (144) −23,588 -$84.5K EDGAR
2026-05-19 RXRX Tax (F) −62,701 -$190.6K EDGAR
2026-03-11 RXRX Sell (S) −28,298 -$94.7K EDGAR
2026-03-09 RXRX Notice (144) −28,298 -$94.7K EDGAR
2026-02-19 RXRX Tax (F) −14,280 -$49.8K EDGAR
2026-02-10 RXRX Mixed +1,693,528 -$41.2K EDGAR
2025-12-29 RXRX Sell (S) −124,403 -$548.6K EDGAR
2025-12-22 RXRX Notice (144) −124,403 -$548.6K EDGAR
Showing 110 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.